Aihe-ehdotuksia
Aihe-ehdotuksia
- COVID-19 12
- COVID-19 (Disease) 12
- Coronaviruses
- Research 12
- SARS-CoV-2 12
- Spike Glycoprotein, Coronavirus
- virology 12
- COVID-19 Pandemic, 2020- 6
- COVID-19 Vaccines 6
- Coronavirus infections 6
- Genetic Variation 6
- Mutation 6
- SARS-CoV-2 variants 6
- genetics 6
- pathogenicity 6
- Angiotensin-Converting Enzyme 2 4
- Antiviral Agents 4
- Cell receptors 4
- Coronavirus Infections 4
- Development 4
- Drug development 4
- Endocytosis 4
- Epidemiological Monitoring 4
- Genetics 4
- Genome, Viral 4
- Host-virus relationships 4
- Vaccination 4
- Vaccines 4
- Virus Internalization 4
- Virus Replication 4
-
1
SARS-CoV-2 evolution within and between individuals
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni -
2
Genetic surveillance and the emergence of SARS-CoV-2 variants
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni -
3
The role of short linear motifs (SLiMs) in SARS-CoV-2 entry into human cells
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni -
4
The role of Neuropilin-1 as a SARS-CoV-2-specific endocytosis potentiator
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni -
5
-
6
SARS-CoV-2 mutations phenotypes and implications for vaccine development /
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni -
7
SARS-CoV-2 mutations phenotypes and implications for vaccine development /
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni -
8
-
9
The role of Neuropilin-1 as a SARS-CoV-2-specific endocytosis potentiator
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni -
10
The role of short linear motifs (SLiMs) in SARS-CoV-2 entry into human cells
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni -
11
Genetic surveillance and the emergence of SARS-CoV-2 variants
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni -
12
SARS-CoV-2 evolution within and between individuals
Julkaistu 2021Hae kokoteksti
Series
Elektroninen Ääni
